Company Description

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health.

Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis.

Evofem Biosciences, Inc. is headquartered in San Diego, California.

Evofem Biosciences, Inc.

Country	United States
Industry	Biotechnology
Sector	Healthcare
Employees	37
CEO	Ms. Saundra Pelletier

Contact Details

Address: 12400 High Bluff Drive, Suite 600 San Diego, California 92130 United States
Phone	(858) 550-1900
Website	evofem.com

Stock Details

Ticker Symbol	EVFM
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001618835
CUSIP Number	30048L104
ISIN Number	US30048L3024
Employer ID	20-8527075
SIC Code	2834

Key Executives

Name	Position
Saundra Pelletier	Interim Chair, President and Chief Executive Officer
Ivy Zhang	Chief Financial Officer and Secretary
Amy Raskopf	Senior Vice President of Investor Relations
Kathy Gallo-Doyle	Vice President of Sales
Rachael Hildebrandt P.H.R.	Head of Human Resources
Ellen Thomas	Chief of Staff

Latest SEC Filings

Date	Type	Title
Mar 28, 2024	8-K	Current Report
Mar 27, 2024	10-K	Annual Report
Mar 27, 2024	8-K	Current Report
Mar 6, 2024	8-K	Current Report
Feb 14, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 1, 2024	8-K	Current Report
Jan 31, 2024	8-K	Current Report
Jan 25, 2024	8-K/A	[Amend] Current report
Jan 11, 2024	8-K	Current Report
Dec 27, 2023	8-K	Current Report

View All SEC Filings